跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL DACARBAZINE FOR INJECTION 200 mg - HSA Drug Approval Details
Approvals
/
HSA
/
DBL DACARBAZINE FOR INJECTION 200 mg
Approved
THERAPEUTIC
DBL DACARBAZINE FOR INJECTION 200 mg
Zydus Hospira Oncology Private Limited (ZHOPL)
🇸🇬 Health Sciences Authority
Approval Date
Jul 8, 1991
Approval ID
3c977069712b49a9
Company
Zydus Hospira Oncology Private Limited (ZHOPL)
Type
Therapeutic
Approval Details
Approval Id
3c977069712b49a9
Drug Name
DBL DACARBAZINE FOR INJECTION 200 mg
Product Name
DBL DACARBAZINE FOR INJECTION 200 mg
Approval Number
SIN06424P
Approval Date
1991-07-08
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01AX04
Atc Item Name
dacarbazine
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Company Detail Path
/organization/pfizer-private-limited
Active Ingredients
DACARBAZINE
200 mg/vial
DACARBAZINE
200 mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 8, 1991
Approval ID
3c977069712b49a9
Type
Therapeutic
Back to HSA Approvals